Skip to content


Technology Platform: UCD Pre-Clinical Molecular Imaging Facility [SFI-funded]

About Us

In vivo imaging of molecular events in animal models holds significant potential in areas like oncology, cardiovascular disease, neurology, diabetes, infectious disease and inflammation research. Molecular imaging is also an essential tool for translational research and new drug development, with the rapid emergence of imaging-based biomarkers. The development of multi-modality methodologies based on PET, SPECT, MRI, CT, ultrasound and optical imaging is the single biggest focus in many imaging centres worldwide.

UCD has made major progress in recent years in establishing a comprehensive suite of state-of-the-art preclinical imaging modalities via two SFI Equipment Awards in 2006 and 2007 (circa 2 million euro in total), alongside infrastructural support from the HRB and internal UCD funds. This dedicated small animal-focused Molecular Imaging Facility houses Ireland’s only integrated small animal PET/CT and SPECT/CT systems.  Complementary in vivo imaging facilities present within UCD include an IVIS Spectrum optical imaging system, Vevo 770 ultrasound device and Zeiss Axioskop 2 confocal intravital microscope.

Optical Imaging

PET Imaging

SPECT Imaging

microCT Imaging


Intravital Microscope

Services, Expertise and Training



For general enquires, including collaborative research studies, contact Prof. William Gallagher ( for further details.

For technical details relating to optical, microCT and radionuclide imaging systems, contact Ms. Emer Conroy (